Scott Bizily
Net worth: 87 721 $ as of 2026-07-30
Net worth: 87 721 $ as of 2026-07-30
Dr. Scott P.
Bizily is a Secretary, Chief Compliance & Legal Officer at 4D Molecular Therapeutics, Inc. Dr. Bizily was previously employed as a General Counsel by Synthego Corp.
and a Director-Corporate Counsel by BioMarin Pharmaceutical, Inc. He received his graduate degree from the University of Pennsylvania and a doctorate degree from the University of Georgia.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-08-16 | 8,617 ( 0.02% ) | 87 721 $ | 2026-07-30 |
| Companies | Position | Start |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Compliance Officer | 2021-11-30 |
| Companies | Position | End |
|---|---|---|
Synthego Corp.
Synthego Corp. BiotechnologyHealth Technology Engages in research, development and manufactures CRISPR cell & gene therapies | General Counsel | 2021-08-31 |
| BIOMARIN PHARMACEUTICAL INC. | General Counsel | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Synthego Corp.
Synthego Corp. BiotechnologyHealth Technology Engages in research, development and manufactures CRISPR cell & gene therapies | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Georgia
University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Select your edition
All financial news and data tailored to specific country editions